Mirum Pharmaceuticals (MIRM) News Today $73.87 -1.66 (-2.20%) Closing price 04:00 PM EasternExtended Trading$72.93 -0.94 (-1.28%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MIRM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Price T Rowe Associates Inc. MD Sells 7,592 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 29 at 4:05 AM | marketbeat.comAffinity Asset Advisors LLC Trims Stake in Mirum Pharmaceuticals, Inc. $MIRMAugust 28 at 9:09 AM | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Stock Position Raised by Capital Fund Management S.A.August 28 at 4:51 AM | marketbeat.comMirum Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 27 at 4:02 PM | businesswire.comMirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year High - Time to Buy?August 27 at 11:42 AM | marketbeat.comWall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to BuyAugust 27 at 3:22 AM | marketbeat.comAlphaQuest LLC Purchases 20,751 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 26 at 5:31 AM | marketbeat.comCharles Schwab Investment Management Inc. Has $14.77 Million Stock Position in Mirum Pharmaceuticals, Inc. $MIRMAugust 26 at 3:05 AM | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Rating Lowered to Buy at Wall Street ZenAugust 26 at 2:03 AM | americanbankingnews.comInvesco Ltd. Boosts Stock Position in Mirum Pharmaceuticals, Inc. $MIRMAugust 25, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $74.13 Consensus PT from AnalystsAugust 25, 2025 | americanbankingnews.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of "Buy" by BrokeragesAugust 24, 2025 | marketbeat.comVanguard Group Inc. Purchases 115,327 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 24, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Shares Sold by Candriam S.C.A.August 23, 2025 | marketbeat.comEntryPoint Capital LLC Makes New $436,000 Investment in Mirum Pharmaceuticals, Inc. $MIRMAugust 23, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Hits New 1-Year High - What's Next?August 21, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 203,489 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 21, 2025 | marketbeat.com15,691 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by Fox Run Management L.L.C.August 19, 2025 | marketbeat.comNuveen LLC Buys New Shares in Mirum Pharmaceuticals, Inc. $MIRMAugust 19, 2025 | marketbeat.comWall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Strong-BuyAugust 19, 2025 | americanbankingnews.comWall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to "Strong-Buy"August 18, 2025 | marketbeat.comE Fund Management Co. Ltd. Makes New $218,000 Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)August 17, 2025 | marketbeat.comDeutsche Bank AG Purchases 71,421 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)August 16, 2025 | marketbeat.comInsider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) CEO Sells 40,000 Shares of StockAugust 14, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 12-Month High - Here's WhyAugust 14, 2025 | marketbeat.comChristopher Peetz Sells 40,000 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) StockAugust 13, 2025 | insidertrades.comMirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Up 9.1% After Analyst UpgradeAugust 12, 2025 | marketbeat.comStifel Nicolaus Reiterates "Buy" Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)August 12, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)August 12, 2025 | marketbeat.comMirum Pharmaceuticals: Q2 Results Continue To Show Positive MomentumAugust 11, 2025 | seekingalpha.comCantor Fitzgerald Brokers Boost Earnings Estimates for MIRMAugust 11, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for MIRM EarningsAugust 11, 2025 | marketbeat.comLeerink Partnrs Has Bullish Forecast for MIRM Q3 EarningsAugust 11, 2025 | marketbeat.comInsider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells $580,000.00 in StockAugust 10, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) CEO Sells $2,210,000.00 in StockAugust 10, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Stock Rating Upgraded by Wall Street ZenAugust 10, 2025 | marketbeat.comEarnings Beat: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsAugust 9, 2025 | finance.yahoo.comEvercore ISI Boosts Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $89.00August 9, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells $580,000.00 in StockAugust 9, 2025 | insidertrades.comMirum Pharmaceuticals Joins Rank Of Stocks With RS Ratings Over 90August 8, 2025 | msn.comMirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $81.00August 8, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week High on Better-Than-Expected EarningsAugust 8, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $82.00 at Raymond James FinancialAugust 8, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | insidermonkey.comHC Wainwright Boosts Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $80.00August 8, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comMirum Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comMirum Pharmaceuticals soars as revenue crushes estimatesAugust 6, 2025 | au.investing.comMirum Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 6, 2025 | finance.yahoo.comJefferies Financial Group Inc. Makes New Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)August 5, 2025 | marketbeat.com Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MIRM Media Mentions By Week MIRM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRM News Sentiment▼1.181.03▲Average Medical News Sentiment MIRM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRM Articles This Week▼166▲MIRM Articles Average Week Get the Latest News and Ratings for MIRM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Viatris News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today QIAGEN News Today Moderna News Today BridgeBio Pharma News Today Elanco Animal Health News Today Verona Pharma PLC American Depositary Share News Today Roivant Sciences News Today Grifols News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MIRM) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access